Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Cherokee Nation Assurance, Contracting Agency to the Division of Viral Diseases, Atlanta, Georgia, United States of America.
PLoS One. 2021 Nov 2;16(11):e0259099. doi: 10.1371/journal.pone.0259099. eCollection 2021.
Polioviruses are positive-sense, single-stranded RNA picornaviruses and the principal cause of poliomyelitis. Global poliovirus surveillance has relied on poliovirus isolation in cells, which may take a minimum of 10 days, involves maintaining two cell lines, and propagates virus in high titers. With eradication underway, a major objective of the Global Polio Eradication Initiative (GPEI) is to develop culture-independent detection of polioviruses as an alternative method to complement the current virus isolation technique. A culture-independent method on poliovirus-positive stool suspensions was assessed with commercially available recombinant soluble poliovirus receptor (PVR) coupled to Histidine (His) tags. Viral RNA was screened by quantitative real-time reverse transcription PCR using the poliovirus intratypic differentiation kit. Poliovirus recovery was optimized with PVR-His-tagged protein and buffers supplemented with polyethylene glycol. To validate the poliovirus-PVR-His tag purification assay, 182 poliovirus-positive stools of programmatic importance were parallel tested against the GPLN-accepted virus isolation method. The PVR-His tag enrichment method detected poliovirus in 164 of 171 poliovirus-positive stools, whereas the virus isolation method misidentified 38 stools as poliovirus-negative (McNemar χ2 p<0.0001). Using this method in combination with RNA extraction, viral RNA recovery increased and showed similar (WPV1) or higher (Sabin 1) sensitivity than the World Health Organization accredited variation of the virus isolation method. The PVR-His enrichment method could be a viable addition to poliovirus surveillance; similar methods have the potential to capture other human pathogens such as EV71 using an appropriate soluble His tag receptor.
脊灰病毒是正链、单链 RNA 小 RNA 病毒,是脊髓灰质炎的主要病原体。全球脊灰病毒监测依赖于细胞中的脊灰病毒分离,这可能需要至少 10 天的时间,需要维持两种细胞系,并以高滴度繁殖病毒。随着根除工作的进行,全球根除脊灰病毒倡议(GPEI)的主要目标之一是开发无细胞培养的脊灰病毒检测方法,作为补充当前病毒分离技术的替代方法。利用与组氨酸(His)标签连接的商业上可获得的重组可溶性脊灰病毒受体(PVR),评估了脊灰病毒阳性粪便悬液的无细胞培养检测方法。使用脊灰病毒种内分化试剂盒通过定量实时逆转录 PCR 筛选病毒 RNA。通过添加聚乙二醇的 PVR-His 标记蛋白和缓冲液优化病毒回收。为了验证脊灰病毒-PVR-His 标签纯化检测法,针对具有项目重要性的 182 份脊灰病毒阳性粪便,与公认的 GPLN 病毒分离方法平行进行了测试。PVR-His 标签富集方法在 171 份脊灰病毒阳性粪便中的 164 份中检测到脊灰病毒,而病毒分离方法错误地将 38 份粪便鉴定为脊灰病毒阴性(McNemar χ2 p<0.0001)。使用该方法与 RNA 提取相结合,提高了病毒 RNA 的回收率,并显示出与世界卫生组织认可的病毒分离方法的变化相似(WPV1)或更高(Sabin 1)的灵敏度。PVR-His 富集方法可以作为脊灰病毒监测的一种可行方法;类似的方法有可能使用适当的可溶性 His 标签受体捕获其他人类病原体,如 EV71。